Media/Press
From Soy Waste to Superfood: Meet Okara!
What if the by-product of soy milk and tofu could become the next big thing in plant-based nutrition? Enter okara—rich in fiber, protein, and bioactive compounds.
it was a strategic occasion for Solaris Biotech. We leave with a clear roadmap: simplify our sales process, leverage smarter lead qualification, and integrate AI-driven tools to boost efficiency.
Events like Mantova Università Aperta are essential for building bridges between academia and industry
Here we discover how Donaldson and its subsidiary, Solaris Biotech, are providing advanced solutions
that ensure regulatory compliance, process efficiency, and product integrity in fermentation-based
production, in doing so supporting the seamless scaleup of alternative proteins
From specialized bioreactors to end-to-end project support, discover how Solaris Biotech is empowering the cultivated meat sector to achieve commercial-scale production and build a more sustainable food future.
Solaris made a successful debut at Analytica China 2024, held from November 18-20 at the Shanghai New International Expo Centre.
This article explores the innovative cultivation of human intestinal organoids (HIOs) in bioreactors, demonstrating how controlled suspension culture can enhance organoid growth and development. The study highlights the potential applications of organoid technology in regenerative medicine, drug screening, and personalized treatments.
This month, Solaris Biotech proudly hosted its annual Global Sales Week, an exciting and engaging event designed to empower our team with cutting-edge knowledge, hands-on training, and strategic insights.
We are thrilled to share an insightful interview with our Sales Leader Emea at Solaris Biotech, featured in Vegconomist
We are thrilled to announce the launch of our new corporate video, highlighting our commitment to groundbreaking advancements in biotechnology.